Related Experiment Video
Updated: Apr 30, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
Comparative cancer survival in European countries.
1Cancer Research Division, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK a.j.munro@dundee.ac.uk.
British Medical Bulletin
|May 13, 2014
Summary
Cancer survival rates differ significantly across Europe. National socio-economic factors, not just drug access or diagnosis timing, strongly influence patient outcomes, necessitating data-driven healthcare strategies.
Area of Science:
- Oncology
- Public Health
- Health Services Research
Background:
- Cancer survival rates exhibit considerable variation across European nations.
- Understanding the determinants of this disparity is crucial for improving patient outcomes.
Purpose of the Study:
- To explore factors influencing cancer survival variations in Europe.
- To identify key drivers of disparities in cancer patient outcomes.
Main Methods:
- Analysis of cancer survival data from EUROCARE-5 and OECD reports.
- Integration of data from multiple sources including EUROSTAT, The World Bank, and WHO.
Main Results:
- National socio-economic factors significantly impact cancer patient outcomes.
- The influence of factors like drug access, delayed diagnosis, and late presentation may be less than commonly assumed.
Conclusions:
- Healthcare systems must re-evaluate strategies to address cancer outcome disparities.
- Enhanced national cancer registries with detailed patient data are essential for evidence-based improvements.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
862
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
862
01:20Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
01:24Kaplan-Meier Approach
791
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
791
01:18Survival Curves
930
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
930
01:20Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K